HDB Earnings

HDB reported its FY2025Q3 earnings on 2025-01-22, showcasing a revenue of 421.07B against an estimate of 422.93B, resulting in a -0.44% surprise. The EPS was 0.82, surpassing the expected 0.74 by 10.81%. The stock experienced a 3.09% price change on the earnings day and a 2.51% change over the next five days, reflecting market reactions to the results.

Following HDB's FY2025Q3 earnings announcement on 2025-01-22, the stock price moved by 3.09% on the day of the release. Over the subsequent five days, it saw a 2.51% change. Historically, HDB's stock price tends to shift by an average of 2.04% in the 10 days leading up to earnings and -1.41% in the 10 days following, providing insight into potential market.

For 2026/Q3, analysts estimate HDB's annual revenue to reach 461.18B, while the EPS is projected at 0.42. These estimates reflect recent revisions, with revenue estimates revised downward by -0.01% and EPS estimates revised upward by 0.28% over the past three months, indicating analyst expectation in the company's performance.

The correlation between HDB's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2026 were revised downward by -0.01%, while EPS estimates moved revised upward by 0.28%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, HDB's stock price typically moves by 2.04% in the 10 days before its earnings and -1.41% in the 10 days after. For the upcoming 2026/Q3 earnings, analysts expect an EPS of 0.42 and revenue of 461.18B.

The earnings call presents a mixed sentiment. While there is optimism with credit growth, stable asset quality, and strategic plans for loan growth and branch expansion, there are concerns about liquidity challenges, CD ratio issues, and unclear management responses to key questions. The sentiment is balanced by positive guidance on asset quality and economic indicators, but the uncertainty in liquidity and funding constraints tempers the overall outlook. Without a clear market cap, the stock's reaction is uncertain, leading to a neutral prediction.